PRKCD and metabolic dysfunction-associated steatohepatitis: We have previously shown that α-SMA was significantly increased in the methionine–choline-deficient (MCD) diet mice and that the inhibition of PKCδ ameliorated hepatic steatosis, suggesting PKCδ participation in the progression of non-alcoholic steatohepatitis (NASH) [29].